Related Experiment Videos
Apparent glucose utilization in Walker 256 metastatic brain tumors
Journal of Neuro-Oncology
|January 1, 1986
Summary
Metastatic brain tumors show high glucose utilization (GU) compared to normal brain tissue. This increased uptake of 2-deoxyglucose by tumor cells offers potential for diagnostic imaging and targeted cancer therapies.
Area of Science:
- Neuroscience
- Oncology
- Biochemistry
Background:
- Metastatic brain tumors present unique metabolic challenges.
- Understanding glucose metabolism in tumors is crucial for diagnosis and treatment.
Purpose of the Study:
- To measure regional glucose utilization (GU) in metastatic Walker 256 (WL-256) brain tumors.
- To assess the diagnostic and therapeutic potential of glucose analogue uptake.
Main Methods:
- Utilized 14C-deoxyglucose and quantitative autoradiography in a rat model.
- Administered WL-256 tumor cells via intracarotid injection.
Main Results:
- Apparent GU was uniform within small/medium tumors without necrosis but varied between tumors.
- High GU in viable tumor regions was 1.3-3 times higher than adjacent normal brain.
- Local cerebral glucose utilization (LCGU) was reduced in remote brain areas, proportional to tumor burden.
Conclusions:
- Viable tumor cells exhibit high 2-deoxyglucose uptake, valuable for tumor diagnosis and localization.
- Glucose analogues could be developed for tumor-selective glycolysis inhibition and tumoricidal effects.